A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice

European Journal of Cancer

Volumn 37, Issue 1, 2001, Pages 106-113

  Lee, J ^a   Weber, M ^a   Mejia, S ^a   Bone, E ^b   Watson, P ^a   Orr, W ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Bone, matrix metalloproteinase; Neoplasm metastasis; Proteinase inhibitor

Indexed keywords

BATIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER INHIBITION; CARCINOGENESIS; CONCENTRATION RESPONSE; CORTICAL BONE; DRUG EFFECT; ENZYME INHIBITION; ENZYMOLOGY; HUMAN; HUMAN CELL; MOUSE; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; PHENYLALANINE; THIOPHENES; TUMOR CELLS, CULTURED;

EID: 0035144531     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00363-4     Document Type: Article

References (32)

1. Mechanisms of bone metastasis
2. Tumour infiltrating macrophages are capable of bone resorption
3. Direct resorption of bone by human breast cancer cells in vitro
4. Direct osteolysis induced by metastatic murine melanoma cells: Role of matrix metalloproteinases
5. Pathophysiologic interactions in skeletal metastasis
6. Bone metastases - The clinical problem
7. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone
8. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion
9. Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells
10. Effects of alendronate and taxol on pc 3 ml cell bone metastases in scid mice
11. Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells
12. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase 2
13. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats
14. Human metastatic prostate PC3 cell lines degrade bone using matrix metalloproteinases
15. The distribution of secondary growths in cancer of the breast
16. Chemotactic activity of bone and platelet-derived TGF-beta for bone-metastasizing rat walker 256 carcinosarcoma cells
17. Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis
18. Increased expression of c-myc mRNA and protein in walker 256 cancer cells stimulated by bone-derived conditioned media and by transforming factor-B (TGF-B)
19. Transforming growth factor beta upregulates the integrin-mediated adhesion of human prostatic carcinoma cells to type I collagen
20. Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells
21. Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells
22. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma
23. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro
24. Inhibition of tumour cell invasion by protease inhibitors: Correlation with the protease profile
25. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9
26. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
27. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells
28. Matrix metalloproteinase inhibitors: A novel class of anticancer agents
29. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice
30. Molecular mechanisms of osteolytic bone metastases
31. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
32. Detection and clinical importance of micrometastatic disease